Abstract
Critically ill patients are frequently at risk of sepsis or inflammatory conditions. Procalcitonin (PCT) is a biomarker for critically ill patients to differentiate sepsis from non-infectious triggers of the systemic inflammatory response syndrome. It has been recently shown that PCT is a valuable tool to guide antibiotic treatment in patients with bacteria infections. However, PCT is also less than a universal and perfect biomarker, and its physiologic role remains unknown. An increase in PCT is associated not only with localized bacterial infection, but also with non-infectious disease or other microbial infections. Numerous studies have suggested that use of PCT would reduce patients’ exposure to antibiotics; however, the use of PCT-guided management of antibiotics strategy needs further study to validate their safety in daily practice in ICU settings. Data supporting this concept from randomized trials are still required. Future studies should focus on PCT kinetics. On the other hand, the need for biologic role of PCT shall be highlighted. Immunoneutralization of PCT will likely be a therapeutic approach for human sepsis only if its physiologic effects are elaborated. The aim of this review is to summarize and discuss the current evidence for PCT in a series of clinical settings.
Similar content being viewed by others
Abbreviations
- PCT:
-
Procalcitonin
- SIRS:
-
The systemic inflammatory response syndrome
- CT:
-
Calcitonin
- CALC-I:
-
Calcitonin-I
- NProCT:
-
N-Procalcitonin part
- CCP-I:
-
CT carboxyl terminal peptide
- CRP:
-
C-reactive protein
- CAP:
-
Community acquired pneumonia
- ICUs:
-
Intensive care units
- CAP:
-
Community acquired pneumonia
- CGRP:
-
Calcitonin gene-related peptide
- MALDI-TOF MS:
-
Matrix-assisted laser desorption/ ionization time of flight mass spectrometry
- MTC:
-
Medullary thyroid carcinoma
- IFN-c:
-
Interferon-c
References
O’Brien DJ, Gould IM (2013) Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts. Curr Opin Infect Dis 26(4):352–358. doi:10.1097/QCO.0b013e3283631046
Uzzan B, Cohen R, Nicolas P et al (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34(7):1996–2003. doi:10.1097/01.CCM.0000226413.54364.36
Schuetz P, Albrich W, Mueller B (2011) Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107. doi:10.1186/1741-7015-9-107
Albrich WC, Dusemund F, Bucher B et al (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter poststudy survey (ProREAL). Arch Intern Med 172(9):715–722. doi:10.1001/archinternmed.2012.770
Al-Nakeeb S, Clermont G (2005) Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections. Crit Care 9(3):E5. doi:10.1186/cc3496
Briel M, Schuetz P, Mueller B et al (2008) Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 168(18):2000–2007. doi:10.1001/archinte.168.18.2000 discussion 2007–2008
Moya F, Nieto A, R-Candela JL (1975) Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem FEBS 55 (2):407–413
Jacobs JW, Goodman RH, Chin WW et al (1981) Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science 213(4506):457–459
Becker KL, Nylen ES, White JC et al (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89(4):1512–1525. doi:10.1210/jc.2002-021444
Gilbert DN (2011) Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis Off Publ Infect Dis Soc Am 52(Suppl 4):S346–S350. doi:10.1093/cid/cir050
Morgenthaler NG, Struck J, Fischer-Schulz C et al (2002) Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 48(5):788–790
Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36(3):941–952. doi:10.1097/CCM.0B013E318165BABB
Niederman MS (2008) Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis Off Publ Infect Dis Soc Am 47(Suppl 3):S127–S132. doi:10.1086/591393
Steinbach G, Rau B, Debard AL et al (2004) Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med CCLM/FESCC 42(4):440–449. doi:10.1515/cclm.2004.077
Menendez R, Martinez R, Reyes S et al (2009) Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64(7):587–591. doi:10.1136/thx.2008.105312
Muller B, White JC, Nylen ES et al (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86(1):396–404
Linscheid P, Seboek D, Nylen ES et al (2003) In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144(12):5578–5584. doi:10.1210/en.2003-0854
Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79(6):1605–1608. doi:10.1210/jcem.79.6.7989463
Sylvie Opatrná, Jan Klaboch, Karel Opatrný Jr et al (2005) Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int (25):470–472
Preas HL 2nd, Nylen ES, Snider RH et al (2001) Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184:373–376
Kapoor S (2009) Procalcitonin and its utility as a diagnostic and prognostic assay in patients with renal dysfunction and immunosuppressive conditions. J Infect Chemother Off J Jpn Soc Chemother 15(1):58. doi:10.1007/s10156-008-0650-z author reply 59
Amour J, Birenbaum A, Langeron O et al (2008) Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36(4):1147–1154. doi:10.1097/CCM.0b013e3181692966
Li HX, Liu ZM, Zhao SJ et al (2014) Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients. J Int Med Res 42(4):1050–1059. doi:10.1177/0300060514528483
Lin KH, Wang FL, Wu MS et al (2014) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis 80(1):72–78. doi:10.1016/j.diagmicrobio.2014.03.029
van der Starre WE, Zunder SM, Vollaard AM et al (2014) Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection. Clin Microbiol Infect. doi:10.1111/1469-0691.12645
Meisner M, Tschaikowsky K, Palmaers T et al (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3(1):45–50. doi:10.1186/cc306
Luzzani A, Polati E, Dorizzi R et al (2003) Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31(6):1737–1741. doi:10.1097/01.CCM.0000063440.19188.ED
Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis Off Publ Infectious Dis Soc Am 39(2):206–217. doi:10.1086/421997
Oliveira CF, Botoni FA, Oliveira CR et al (2013) Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 41(10):2336–2343. doi:10.1097/CCM.0b013e31828e969f
Gaini S, Koldkjaer OG, Pedersen C et al (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10(2):R53. doi:10.1186/cc4866
Watkin RW, Harper LV, Vernallis AB et al (2007) Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect 55(3):220–225. doi:10.1016/j.jinf.2007.05.174
Chauveau P, Level C, Lasseur C et al (2003) C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study. J Renal Nutr Off J Counc Renal Nutr Natl Kidney Found 13(2):137–143. doi:10.1053/jren.2003.50017
van Vugt SF, Broekhuizen BD, Lammens C et al (2013) Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 346:f2450. doi:10.1136/bmj.f2450
Daniels JM, Schoorl M, Snijders D et al (2010) Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138(5):1108–1115. doi:10.1378/chest.09-2927
Magrini L, Gagliano G, Travaglino F et al (2014) Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med 52(10):1465–1472. doi:10.1515/cclm-2014-0210
Sanchez-Yepes M, Aznar-Oroval E, Lorente-Alegre P et al (2014) Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant. Enferm Infecc Microbiol Clin 32(7):418–423. doi:10.1016/j.eimc.2013.09.003
Macrina F, Tritapepe L, Pompei F et al (2005) Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery. Perfusion 20(3):169–175
Nikfar R, Khotaee G, Ataee N et al (2010) Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department. Pediatr Int 52(2):196–198. doi:10.1111/j.1442-200X.2009.002917.x
Mofidi RSS, Patil PV, Ogston S et al (2009) The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 146(1):72–81. doi:10.1016/j.surg.2009.02.013
Yousif M, El-Helbawy R, HaE-H AmrDarwish (2012) Usefulness of procalcitonin as a diagnostic marker of pleural effusion. J Am Sci 8:7
Shen CJ, Wu MS, Lin KH et al (2013) The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis 32(6):807–814. doi:10.1007/s10096-012-1812-6
Sakr Y, Sponholz C, Tuche F et al (2008) The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 36(5):396–407. doi:10.1007/s15010-008-7374-y
Shi Y, Zhang HM, Liu Y et al (2012) The value of procalcitonin for diagnosing infection in critically ill patients receiving long-term immunosuppressive therapy. Zhonghua nei ke za zhi 51(3):192–196
Ingram PR, Inglis T, Moxon D et al (2010) Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 36(3):528–532. doi:10.1007/s00134-009-1746-3
Uzzan B, Izri A, Durand R, Deniau M, Bouchaud O, Perret GY (2006) Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study. Travel Med Infect Dis 4(2):77–80. doi:10.1016/j.tmaid.2005.04.003
Hollenstein U, Looareesuwan S, Aichelburg A et al (1998) Serum procalcitonin levels in severe Plasmodium falciparum malaria. Am J Trop Med Hyg 59(6):860–863
Oku E, Nomura K, Nakamura T et al (2012) Amebic colitis and liver abscess complicated by high serum procalcitonin in acute myeloid leukemia. Kansenshogaku zasshi 86(6):773–777
Peter JV, Karthik G, Ramakrishna K et al (2013) Elevated procalcitonin is associated with increased mortality in patients with scrub typhus infection needing intensive care admission. Indian J Crit Care Med 17(3):174–177. doi:10.4103/0972-5229.117063
Reinhart K, Bauer M, Riedemann NC et al (2012) New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 25(4):609–634. doi:10.1128/CMR.00016-12
Karlsson S, Heikkinen M, Pettila V et al (2010) Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 14(6):R205. doi:10.1186/cc9327
Meidani MKF, Abolghasemi H, Jamali B (2013) Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer 2(4):216–219. doi:10.4103/2278-330x.119913
Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 13(5):426–435. doi:10.1016/S1473-3099(12)70323-7
Afshari A, Harbarth S (2013) Procalcitonin as diagnostic biomarker of sepsis. Lancet Infect Dis. 13(5):382–384. doi:10.1016/S1473-3099(13)70026-4
Broad PM, Symes AJ, Thakker RV et al (1989) Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res 17(17):6999–7011
Christ-Crain M, Jaccard-Stolz D, Bingisser R et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409):600–607. doi:10.1016/s0140-6736(04)15591-8
Christ-Crain M, Stolz D, Bingisser R et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Respir Crit Care Med 174(1):84–93. doi:10.1164/rccm.200512-1922OC
Ding J, Chen Z, Feng K (2013) Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci. 10(7):903–907. doi:10.7150/ijms.4972
Stolz DC-CM, Bingisser R, Leuppi J et al (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131(1):9–19. doi:10.1378/chest.06-1500
Schuetz PCV, Briel M, Greenwald JL (2011) Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 171(15):1322–1331. doi:10.1001/archinternmed.2011.318
Hochreiter M, Kohler T, Schweiger AM et al (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13(3):R83. doi:10.1186/cc7903
Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474. doi:10.1016/s0140-6736(09)61879-1
Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058. doi:10.1097/CCM.0b013e31821e8791
Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3):210–217. doi:10.1016/s1473-3099(07)70052-x
Jones AE, Fiechtl JF, Brown MD et al (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50(1):34–41. doi:10.1016/j.annemergmed.2006.10.020
Christ-Crain M, Muller B (2005) Procalcitonin in bacterial infections–hype, hope, more or less? Swiss Med Wkly 135(31–32):451–460 2005/31/smw-11169
Gilbert DN (2010) Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 48(7):2325–2329. doi:10.1128/JCM.00655-10
Tavares E, Minano FJ (2010) Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies. Clin Sci 119(12):519–534. doi:10.1042/CS20100007
Lindberg M, Hole A, Johnsen H et al (2002) Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest 62(3):189–194
Sexton PM, Christopoulos G, Christopoulos A et al (2008) Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med 36(5):1637–1640. doi:10.1097/CCM.0b013e318170a554
Monneret G, Arpin M, Venet F et al (2003) Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med 29(6):923–928. doi:10.1007/s00134-003-1759-2
Araujo M, Doi SQ, Palant CE et al (2013) Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury. Inflamm Res Off J Eur Histamine Res Soc 62 (10):887–894. doi:10.1007/s00011-013-0646-8
Liappis AP, Gibbs KW, Nylen ES et al (2011) Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res Off J Eur Histamine Res Soc 60(2):203–207. doi:10.1007/s00011-010-0255-8
Wagner KE, Martinez JM, Vath SD et al (2002) Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 30(10):2313–2321. doi:10.1097/01.CCM.0000030446.45432.43
Becker KL, Snider R, Nylen ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159(2):253–264. doi:10.1111/j.1476-5381.2009.00433.x
Wolff M, Bouadma L (2010) What procalcitonin brings to management of sepsis in the ICU. Crit Care 14(6):1007. doi:10.1186/cc9330
Radimerski TM, Grisouard J, Timper K et al (2011) Role of calcium in lipopolysaccharide-induced calcitonin gene expression in human adipocytes. Innate Immun 17(4):403–413. doi:10.1177/1753425910377100
Zannoni A, Giunti M, Bernardini C et al (2012) Procalcitonin gene expression after LPS stimulation in the porcine animal model. Res Vet Sci 93(2012):921–927. doi:10.1016/j.rvsc.2011.09.011
Oberhoffer M, Stonans I, Russwurm S (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134:49–55
Giunti M, Peli A, Battilani M (2010) Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 20(5):523–527. doi:10.1111/j.1476-4431.2010.00575.x
Russwurm S, Stonans I, Stonane E et al (2001) Procalcitonin and CGRP-I mRNA expression in various human tissues. Shock 16(2):109–112
Kuzi S, Aroch I, Peleg K et al (2008) Canine procalcitonin messenger RNA expression. J Vet Diagn Invest 20(5):629–633. doi:10.1177/104063870802000516
Monneret G, Laroche B, Bienvenu J (1999) Procalcitonin is not produced by circulating blood cells. Infection 27(1):34–35
Snider RH Jr, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45(9):552–560
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, H.H., Guo, J.B., Geng, Y. et al. Procalcitonin: present and future. Ir J Med Sci 184, 597–605 (2015). https://doi.org/10.1007/s11845-015-1327-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-015-1327-0